Nxera Pharma: Received a milestone payment of 10 million US dollars in a drug development partnership with Abbvie targeting neurological diseases.

JPX · Jun 27 07:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.